Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.8 EUR | +9.00% | +19.38% | +91.67% |
Apr. 17 | Medincell: share price rises following agreement with AbbVie | CF |
Apr. 16 | Medincell, AbbVie to Co-Develop Injectable Therapeutics | DJ |
Sales 2024 * | 13.96M 14.96M | Sales 2025 * | 41.88M 44.88M | Capitalization | 397M 425M |
---|---|---|---|---|---|
Net income 2024 * | -23M -24.65M | Net income 2025 * | 1M 1.07M | EV / Sales 2024 * | 31.9 x |
Net Debt 2024 * | 48.73M 52.22M | Net Debt 2025 * | 58.83M 63.04M | EV / Sales 2025 * | 10.9 x |
P/E ratio 2024 * |
-15.1
x | P/E ratio 2025 * |
-259
x | Employees | 138 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 49.98% |
Latest transcript on MedinCell S.A.
1 day | +9.00% | ||
1 week | +19.38% | ||
Current month | +43.90% | ||
1 month | +43.90% | ||
3 months | +65.87% | ||
6 months | +135.90% | ||
Current year | +91.67% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Douat
CEO | Chief Executive Officer | 60 | 03-01-08 |
Stéphane Postic
DFI | Director of Finance/CFO | 50 | 23-08-31 |
Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sabri Markabi
BRD | Director/Board Member | - | 17-07-04 |
Tone Kvåle
BRD | Director/Board Member | 55 | 22-06-12 |
Virginie Lleu
BRD | Director/Board Member | - | 16-05-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 13.8 | +9.00% | 221,319 |
24-04-26 | 12.66 | +2.10% | 93,879 |
24-04-25 | 12.4 | +2.48% | 121,673 |
24-04-24 | 12.1 | -1.47% | 97,316 |
24-04-23 | 12.28 | +6.23% | 197,954 |
Real-time Euronext Paris, April 29, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+91.67% | 389M | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- MEDCL Stock